Wanying Duan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wanying Duan has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
- Liping Liu
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
13 shared publications - Ximing Nie
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
12 shared publications - Jingyi Liu
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
9 shared publications Xin Liu
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
9 shared publications- Yufei Wei
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
9 shared publications - Lina Zheng
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
8 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by BMJ in Stroke and Vascular Neurology
Cognitive reserve and risk of poststroke cognitive impairment in acute ischaemic stroke: post hoc analysis of CATIS-2
Background: The impact of cognitive reserve (CR) on poststroke cognitive impairment (PSCI) remains unclear. This study aimed to investigate the association between CR proxy scores derived from an education-residence proxy index and PSCI. Methods: We conducted a post hoc analysis of the China Acute Ischemic Stroke Hypotension Trial II cohort including acute ischaemic stroke (AIS) patients without prior dementia who completed 3-month cognitive assessment. A CR proxy score was constructed using principal component analysis based on education and residential location. PSCI was defined as Montreal Cognitive Assessment <25. Logistic regression and restricted cubic spline (RCS) analyses were used to examine associations between CR and PSCI. Results: PSCI occurred in 1019 of 1682 patients (60.6%). Higher CR proxy scores were associated with lower odds of PSCI (OR=0.88; 95% CI 0.81 to 0.96; p=0.01), with similar findings in the fully adjusted model (OR=0.89; 95% CI 0.81 to 0.98; p=0.02). RCS analyses showed a linear inverse association between CR proxy scores and PSCI (P overall=0.001; P non-linear=0.35). Component analyses suggested that educational attainment was the predominant contributor to the observed association. Conclusions: The education-residence-based CR proxy score was associated with lower odds of PSCI after AIS. The observed associations require cautious interpretation and further validation using comprehensive CR measures. Trial registration number: NCT03479554 .
- 6 October 2026
- Published by BMJ in Stroke and Vascular Neurology
Open AccessCognitive reserve and risk of poststroke cognitive impairment in acute ischaemic stroke: post hoc analysis of CATIS-2
Background: The impact of cognitive reserve (CR) on poststroke cognitive impairment (PSCI) remains unclear. This study aimed to investigate the association between CR proxy scores derived from an education-residence proxy index and PSCI. Methods: We conducted a post hoc analysis of the China Acute Ischemic Stroke Hypotension Trial II cohort including acute ischaemic stroke (AIS) patients without prior dementia who completed 3-month cognitive assessment. A CR proxy score was constructed using principal component analysis based on education and residential location. PSCI was defined as Montreal Cognitive Assessment <25. Logistic regression and restricted cubic spline (RCS) analyses were used to examine associations between CR and PSCI. Results: PSCI occurred in 1019 of 1682 patients (60.6%). Higher CR proxy scores were associated with lower odds of PSCI (OR=0.88; 95% CI 0.81 to 0.96; p=0.01), with similar findings in the fully adjusted model (OR=0.89; 95% CI 0.81 to 0.98; p=0.02). RCS analyses showed a linear inverse association between CR proxy scores and PSCI (P overall=0.001; P non-linear=0.35). Component analyses suggested that educational attainment was the predominant contributor to the observed association. Conclusions: The education-residence-based CR proxy score was associated with lower odds of PSCI after AIS. The observed associations require cautious interpretation and further validation using comprehensive CR measures. Trial registration number: NCT03479554 .
- 1 September 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (9) , 2620-2630
Low-Field Magnetic Resonance Imaging in Critical Care of Stroke
Neurological deterioration is a frequent and clinically significant challenge in patients with acute stroke admitted to neurocritical care units, where timely neuroimaging is essential but access to advanced imaging may be limited by patient instability and logistical constraints. Low-field magnetic resonance imaging (LF-MRI) has recently emerged as a novel approach to extend MRI capability into critical care environments. This topic review synthesizes current evidence on the feasibility, safety, and evolving clinical applications of LF-MRI in neurocritical care stroke. Existing studies demonstrate its utility in diagnostic clarification, longitudinal monitoring of brain injury, and detection of selected secondary complications. Key applications include intracerebral hemorrhage detection and volumetric assessment, quantification of midline shift, ventricular monitoring, evaluation of infarct evolution and cerebral edema, and assessment of unexplained neurological deterioration. Beyond these applications, LF-MRI offers a unique opportunity to support repeated imaging during periods when neurological examination is unreliable or limited. LF-MRI should be viewed as a complementary imaging modality rather than a replacement for computed tomography or conventional high-field MRI. Future advances in sequence development, workflow integration, and rigorously validated artificial intelligence–assisted quantitative tools are expected to further define its role in risk stratification, time-sensitive decision-making, and longitudinal neurocritical care pathways. As access to portable imaging expands, LF-MRI has the potential to reshape neuroimaging strategies in critically ill patients with stroke.
- 1 September 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (9) , 2620-2630
Low-Field Magnetic Resonance Imaging in Critical Care of Stroke
Neurological deterioration is a frequent and clinically significant challenge in patients with acute stroke admitted to neurocritical care units, where timely neuroimaging is essential but access to advanced imaging may be limited by patient instability and logistical constraints. Low-field magnetic resonance imaging (LF-MRI) has recently emerged as a novel approach to extend MRI capability into critical care environments. This topic review synthesizes current evidence on the feasibility, safety, and evolving clinical applications of LF-MRI in neurocritical care stroke. Existing studies demonstrate its utility in diagnostic clarification, longitudinal monitoring of brain injury, and detection of selected secondary complications. Key applications include intracerebral hemorrhage detection and volumetric assessment, quantification of midline shift, ventricular monitoring, evaluation of infarct evolution and cerebral edema, and assessment of unexplained neurological deterioration. Beyond these applications, LF-MRI offers a unique opportunity to support repeated imaging during periods when neurological examination is unreliable or limited. LF-MRI should be viewed as a complementary imaging modality rather than a replacement for computed tomography or conventional high-field MRI. Future advances in sequence development, workflow integration, and rigorously validated artificial intelligence–assisted quantitative tools are expected to further define its role in risk stratification, time-sensitive decision-making, and longitudinal neurocritical care pathways. As access to portable imaging expands, LF-MRI has the potential to reshape neuroimaging strategies in critically ill patients with stroke.
- Open Access
- 7 July 2026
- Published by BMJ in Stroke and Vascular Neurology
Association between ASPECTS regions and clinical outcomes following endovascular therapy in patients with large infarcts: a post hoc analysis of the ANGEL-ASPECT trial
Objective: To explore whether clinical outcomes following endovascular therapy (EVT) may differ according to infarct regions assessed by the Alberta Stroke Program Early CT Score (ASPECTS) in patients with large infarcts. Methods: This post hoc analysis of the ANGEL-ASPECT study included patients with acute ischaemic stroke due to anterior circulation large vessel occlusion and large infarcts. Patients were randomised to EVT or standard medical therapy (SMT) and stratified based on ASPECTS into two groups: subcortical regions involvement (caudate, lenticular nucleus or internal capsule) and cortical regions involvement (cortical areas). The primary outcome was the 90-day modified Rankin Scale (mRS) score. ANGEL-ASPECT is signed up to ClinicalTrials.gov, NCT04551664 . Results: Of 455 patients, 395 (86.81%) with subcortical regions and 60 (13.19%) cortical regions infarcts. EVT was associated with a favourable shift in 90-day mRS scores in the subcortical regions group (OR 1.65; 95% CI 1.16 to 2.34; p<0.001), whereas no statistically significant difference was observed in the cortical regions group (OR 1.47; 95% CI 0.59 to 3.66; p=0.09). In the subcortical regions group, EVT was associated with better outcomes in left-side infarcts (OR 1.73; 95% CI 1.04 to 2.89; p=0.04). Similar trends were not statistically significant in right-side infarcts (OR 1.57; 95% CI 0.97 to 2.53; p=0.07). Conclusions: In this exploratory post hoc analysis, EVT was associated with more favourable functional outcomes in patients with subcortical region involvement, particularly in left-sided infarcts. However, no significant interaction between infarct location and treatment assignment was observed, and these findings should be considered hypothesis-generating.
- 7 July 2026
- Published by BMJ in Stroke and Vascular Neurology
Open AccessAssociation between ASPECTS regions and clinical outcomes following endovascular therapy in patients with large infarcts: a post hoc analysis of the ANGEL-ASPECT trial
Objective: To explore whether clinical outcomes following endovascular therapy (EVT) may differ according to infarct regions assessed by the Alberta Stroke Program Early CT Score (ASPECTS) in patients with large infarcts. Methods: This post hoc analysis of the ANGEL-ASPECT study included patients with acute ischaemic stroke due to anterior circulation large vessel occlusion and large infarcts. Patients were randomised to EVT or standard medical therapy (SMT) and stratified based on ASPECTS into two groups: subcortical regions involvement (caudate, lenticular nucleus or internal capsule) and cortical regions involvement (cortical areas). The primary outcome was the 90-day modified Rankin Scale (mRS) score. ANGEL-ASPECT is signed up to ClinicalTrials.gov, NCT04551664 . Results: Of 455 patients, 395 (86.81%) with subcortical regions and 60 (13.19%) cortical regions infarcts. EVT was associated with a favourable shift in 90-day mRS scores in the subcortical regions group (OR 1.65; 95% CI 1.16 to 2.34; p<0.001), whereas no statistically significant difference was observed in the cortical regions group (OR 1.47; 95% CI 0.59 to 3.66; p=0.09). In the subcortical regions group, EVT was associated with better outcomes in left-side infarcts (OR 1.73; 95% CI 1.04 to 2.89; p=0.04). Similar trends were not statistically significant in right-side infarcts (OR 1.57; 95% CI 0.97 to 2.53; p=0.07). Conclusions: In this exploratory post hoc analysis, EVT was associated with more favourable functional outcomes in patients with subcortical region involvement, particularly in left-sided infarcts. However, no significant interaction between infarct location and treatment assignment was observed, and these findings should be considered hypothesis-generating.
- Open Access
- 27 May 2026
- Published by BMJ in Stroke and Vascular Neurology
Renal function and effect of early antihypertensive therapy in acute ischaemic stroke: a subgroup analysis of the CATIS-2 trial
Background: The role of renal function in patients with acute ischaemic stroke (AIS) receiving blood pressure (BP) lowering therapy remains incompletely understood. In this prespecified subgroup analysis of the CATIS-2 trial, we tested the hypothesis that baseline estimated glomerular filtration rate (eGFR) affects the relationship between early antihypertensive therapy and outcomes in AIS. Methods: In the CATIS-2 trial, AIS patients were randomly assigned to early treatment (initiating BP-lowering agents within 24–48 hours of stroke onset) or delayed treatment (withholding such agents until day 8). The composite of functional dependence or death (modified Rankin Scale score ≥3) at day 90 was defined as the primary outcome. The treatment effect was analysed between different baseline eGFR values (<90 versus ≥90 mL/min per 1.73 m²). Results: 4685 patients were finally enrolled. Among 1061 patients with eGFR<90, the risk of the primary outcome was higher in early treatment compared with delayed treatment (15.3% vs 10.5%; OR (OR) 1.55, 95% CI 1.07–2.23; p=0.02). In 3624 patients with eGFR≥90, no such difference was observed (10.7% vs 10.2%; OR 1.05, 95% CI 0.85 to 1.30; p=0.63). The interaction was marginally significant (p=0.07). Conclusions: The modification effect of renal function on different antihypertensive timing for AIS was not observed. Further, adequately powered studies were warranted. Trial registration number: NCT03479554 .
- 27 May 2026
- Published by BMJ in Stroke and Vascular Neurology
Open AccessRenal function and effect of early antihypertensive therapy in acute ischaemic stroke: a subgroup analysis of the CATIS-2 trial
Background: The role of renal function in patients with acute ischaemic stroke (AIS) receiving blood pressure (BP) lowering therapy remains incompletely understood. In this prespecified subgroup analysis of the CATIS-2 trial, we tested the hypothesis that baseline estimated glomerular filtration rate (eGFR) affects the relationship between early antihypertensive therapy and outcomes in AIS. Methods: In the CATIS-2 trial, AIS patients were randomly assigned to early treatment (initiating BP-lowering agents within 24–48 hours of stroke onset) or delayed treatment (withholding such agents until day 8). The composite of functional dependence or death (modified Rankin Scale score ≥3) at day 90 was defined as the primary outcome. The treatment effect was analysed between different baseline eGFR values (<90 versus ≥90 mL/min per 1.73 m²). Results: 4685 patients were finally enrolled. Among 1061 patients with eGFR<90, the risk of the primary outcome was higher in early treatment compared with delayed treatment (15.3% vs 10.5%; OR (OR) 1.55, 95% CI 1.07–2.23; p=0.02). In 3624 patients with eGFR≥90, no such difference was observed (10.7% vs 10.2%; OR 1.05, 95% CI 0.85 to 1.30; p=0.63). The interaction was marginally significant (p=0.07). Conclusions: The modification effect of renal function on different antihypertensive timing for AIS was not observed. Further, adequately powered studies were warranted. Trial registration number: NCT03479554 .
- Open Access
Cerebral Microbleeds and the Effect of Early Antihypertensive Treatment in Patients with Acute Ischemic Stroke: A Secondary Analysis of the CATIS-2 Trial
Background and Objectives: To explore whether the presence, burden or distribution of cerebral microbleeds (CMBs) modifies the effect of early versus delayed antihypertensive treatment on clinical outcomes in acute ischemic stroke (AIS) patients. Methods: A secondary analysis of the China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2) trial was performed. Participants with baseline cerebral magnetic resonance imaging (MRI) data for CMB evaluation were included. The primary outcome was functional dependency or death at 90 days, defined as a modified Rankin Scale (mRS) score ≥3. Results: Among 815 eligible participants (mean age 62.4 years; 34.5% female), 396 (48.6%) had at least one CMB. The presence of strictly deep CMBs was associated with an increased risk of functional dependency or death at 90 days compared to the absence of CMBs (15.3% vs 7.9%; adjusted odds ratio [aOR] 1.92, 95% CI 1.08-3.40, P =0.03). Early versus delayed antihypertensive treatment significantly increased the risk of functional dependency or death in patients with CMBs (17.1% vs 8.7%; aOR 2.17, 95% CI 1.16-4.07; P =0.02). This effect was particularly pronounced among patients with moderate-to-severe CMBs (17.5% vs 6.6%; aOR, 2.85; 95% CI, 1.06–7.67; P =0.04) and strictly deep CMBs (20.8% vs 9.0%; aOR, 2.76; 95% CI, 1.15–6.64; P =0.02). However, no statistically significant interaction was observed between CMBs and treatment assignment for the primary outcome ( p interaction >0.05). Conclusions: This secondary analysis of CATIS-2 indicates that the presence of CMBs, particularly those predominantly located in deep regions or with a greater burden, may increase the risk of adverse clinical outcomes following early antihypertensive treatment in AIS patients. These findings highlight the imperative for further research on individualized blood pressure (BP) management strategies in AIS patients with CMBs. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03479554 .
Open AccessCerebral Microbleeds and the Effect of Early Antihypertensive Treatment in Patients with Acute Ischemic Stroke: A Secondary Analysis of the CATIS-2 Trial
Background and Objectives: To explore whether the presence, burden or distribution of cerebral microbleeds (CMBs) modifies the effect of early versus delayed antihypertensive treatment on clinical outcomes in acute ischemic stroke (AIS) patients. Methods: A secondary analysis of the China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2) trial was performed. Participants with baseline cerebral magnetic resonance imaging (MRI) data for CMB evaluation were included. The primary outcome was functional dependency or death at 90 days, defined as a modified Rankin Scale (mRS) score ≥3. Results: Among 815 eligible participants (mean age 62.4 years; 34.5% female), 396 (48.6%) had at least one CMB. The presence of strictly deep CMBs was associated with an increased risk of functional dependency or death at 90 days compared to the absence of CMBs (15.3% vs 7.9%; adjusted odds ratio [aOR] 1.92, 95% CI 1.08-3.40, P =0.03). Early versus delayed antihypertensive treatment significantly increased the risk of functional dependency or death in patients with CMBs (17.1% vs 8.7%; aOR 2.17, 95% CI 1.16-4.07; P =0.02). This effect was particularly pronounced among patients with moderate-to-severe CMBs (17.5% vs 6.6%; aOR, 2.85; 95% CI, 1.06–7.67; P =0.04) and strictly deep CMBs (20.8% vs 9.0%; aOR, 2.76; 95% CI, 1.15–6.64; P =0.02). However, no statistically significant interaction was observed between CMBs and treatment assignment for the primary outcome ( p interaction >0.05). Conclusions: This secondary analysis of CATIS-2 indicates that the presence of CMBs, particularly those predominantly located in deep regions or with a greater burden, may increase the risk of adverse clinical outcomes following early antihypertensive treatment in AIS patients. These findings highlight the imperative for further research on individualized blood pressure (BP) management strategies in AIS patients with CMBs. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03479554 .
- 1 April 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (4) , 1048-1053
Clinical Severity and Outcomes in Large Infarcts With Endovascular Therapy: A Post Hoc Analysis of the ANGEL-ASPECT Trial
BACKGROUND: Endovascular therapy (EVT) has been proven effective for patients with acute ischemic stroke with large infarcts. This study aimed to explore the impact of clinical severity on the efficacy of EVT in such patients. METHODS: This was a post hoc analysis of the ANGEL-ASPECT trial (Endovascular Therapy in Acute Anterior Circulation Large Vessel Occlusive Patients With a Large Infarct Core), a randomized controlled trial that enrolled patients from 46 centers across China between October 2, 2020, and May 18, 2022. These patients had large infarcts (defined as Alberta Stroke Program Early CT Score of 3–5 or infarct-core volume 70–100 mL) due to anterior-circulation large vessel occlusion within 24 hours after stroke onset with a National Institutes of Health Stroke Scale score of 6 to 30. Patients were randomized into either the EVT group or the medical management alone (MM) group. For this analysis, we categorized the patients into 2 subgroups: moderate stroke and severe stroke, based on a baseline National Institutes of Health Stroke Scale score of either P P =0.87), indicating a significant interaction ( P =0.03). CONCLUSIONS: In patients with acute large infarcts, EVT was associated with improved functional outcomes compared with MM in patients with moderate stroke. However, no significant difference was observed in patients with severe stroke. Therefore, stroke severity should be considered when selecting patients with large infarcts for EVT. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04551664.
- 1 April 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (4) , 1048-1053
Clinical Severity and Outcomes in Large Infarcts With Endovascular Therapy: A Post Hoc Analysis of the ANGEL-ASPECT Trial
BACKGROUND: Endovascular therapy (EVT) has been proven effective for patients with acute ischemic stroke with large infarcts. This study aimed to explore the impact of clinical severity on the efficacy of EVT in such patients. METHODS: This was a post hoc analysis of the ANGEL-ASPECT trial (Endovascular Therapy in Acute Anterior Circulation Large Vessel Occlusive Patients With a Large Infarct Core), a randomized controlled trial that enrolled patients from 46 centers across China between October 2, 2020, and May 18, 2022. These patients had large infarcts (defined as Alberta Stroke Program Early CT Score of 3–5 or infarct-core volume 70–100 mL) due to anterior-circulation large vessel occlusion within 24 hours after stroke onset with a National Institutes of Health Stroke Scale score of 6 to 30. Patients were randomized into either the EVT group or the medical management alone (MM) group. For this analysis, we categorized the patients into 2 subgroups: moderate stroke and severe stroke, based on a baseline National Institutes of Health Stroke Scale score of either P P =0.87), indicating a significant interaction ( P =0.03). CONCLUSIONS: In patients with acute large infarcts, EVT was associated with improved functional outcomes compared with MM in patients with moderate stroke. However, no significant difference was observed in patients with severe stroke. Therefore, stroke severity should be considered when selecting patients with large infarcts for EVT. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04551664.
- Open Access
- 2 April 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (7) , e033633
Deviation From Personalized Blood Pressure Targets Correlates With Worse Outcome After Successful Recanalization
Background: Personalized blood pressure (BP) management for patients with acute ischemic stroke after successful endovascular thrombectomy lacks evidence. We aimed to investigate whether the deviation of BP from cerebral autoregulation limits is associated with worse outcomes. Methods and Results: We determined autoregulation by measuring mean velocity index and calculated the percentage of time and the burden (defined as the time‐BP area) with BP outside the autoregulatory limits of each subject within 48 hours after endovascular thrombectomy. In total, 91 patients with large vessel occlusion stroke who had achieved successful recanalization were prospectively enrolled between May 2020 and February 2022. The burden with BP outside the autoregulatory limits was associated with poor outcome (modified Rankin Scale score 3–6) at 90 days (adjusted odds ratio, 1.28 [95% CI, 1.03–1.59]). The percentage of time with BP out of the autoregulatory limits was correlated with early neurological deterioration (National Institute of Health Stroke Scale scores increased ≥2 at 7 days) (adjusted odds ratio, 1.38 [95% CI, 1.04–1.83]). The burden of BP that decreased below the autoregulatory lower limit was associated with significant infarct growth (volume of infarct growth >11.6 mL) at 7 days (adjusted odds ratio, 1.21 [95% CI, 1.01–1.44]). The percentage of time that BP exceeded the autoregulatory upper limit was associated with symptomatic intracranial hemorrhage within 48 hours (adjusted odds ratio, 1.55 [95% CI, 1.02–2.34]). Conclusions: Both the percentage of time and the burden of BP that deviates from the autoregulation‐preserved range are associated with unfavorable clinical outcomes. This study highlights the potential benefits of autoregulation‐guided BP management strategy after successful recanalization.
- 2 April 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (7) , e033633
Open AccessDeviation From Personalized Blood Pressure Targets Correlates With Worse Outcome After Successful Recanalization
Background: Personalized blood pressure (BP) management for patients with acute ischemic stroke after successful endovascular thrombectomy lacks evidence. We aimed to investigate whether the deviation of BP from cerebral autoregulation limits is associated with worse outcomes. Methods and Results: We determined autoregulation by measuring mean velocity index and calculated the percentage of time and the burden (defined as the time‐BP area) with BP outside the autoregulatory limits of each subject within 48 hours after endovascular thrombectomy. In total, 91 patients with large vessel occlusion stroke who had achieved successful recanalization were prospectively enrolled between May 2020 and February 2022. The burden with BP outside the autoregulatory limits was associated with poor outcome (modified Rankin Scale score 3–6) at 90 days (adjusted odds ratio, 1.28 [95% CI, 1.03–1.59]). The percentage of time with BP out of the autoregulatory limits was correlated with early neurological deterioration (National Institute of Health Stroke Scale scores increased ≥2 at 7 days) (adjusted odds ratio, 1.38 [95% CI, 1.04–1.83]). The burden of BP that decreased below the autoregulatory lower limit was associated with significant infarct growth (volume of infarct growth >11.6 mL) at 7 days (adjusted odds ratio, 1.21 [95% CI, 1.01–1.44]). The percentage of time that BP exceeded the autoregulatory upper limit was associated with symptomatic intracranial hemorrhage within 48 hours (adjusted odds ratio, 1.55 [95% CI, 1.02–2.34]). Conclusions: Both the percentage of time and the burden of BP that deviates from the autoregulation‐preserved range are associated with unfavorable clinical outcomes. This study highlights the potential benefits of autoregulation‐guided BP management strategy after successful recanalization.
- Top Cited PapersOpen Access
- 29 December 2023
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 8 (6) , e3
Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update
Background: China is one of the countries with the highest burden of stroke. Implementing multidimensional management guidelines will help clinicians practise evidence-based care, improve patient outcomes and alleviate societal burdens. This update of the 2019 edition will provide the latest comprehensive recommendations for the diagnosis and treatment of ischaemic cerebrovascular diseases. Methods: We conducted a comprehensive search on MEDLINE (via PubMed) up to 31 August 2023. The writing team established the recommendations through multiple rounds of online and offline discussions. Each recommendation was graded using the evidence grading algorithm developed by the Chinese Stroke Association (CSA). The draft was reviewed and finalised by the CSA Stroke Guidelines Writing Committee. Results: This update included revisions of 15 existing recommendations and 136 new recommendations in the following areas of stroke care: emergency assessment and diagnosis of ischaemic cerebrovascular disease, acute-phase reperfusion therapy, evaluation of underlying mechanisms, antithrombotic therapy, prevention and treatment of complications, and risk factor management. Conclusions: This guideline updated the recommendations for the clinical management of ischaemic cerebrovascular disease from 2019.
- 29 December 2023
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 8 (6) , e3
Top Cited PapersOpen AccessChinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update
Background: China is one of the countries with the highest burden of stroke. Implementing multidimensional management guidelines will help clinicians practise evidence-based care, improve patient outcomes and alleviate societal burdens. This update of the 2019 edition will provide the latest comprehensive recommendations for the diagnosis and treatment of ischaemic cerebrovascular diseases. Methods: We conducted a comprehensive search on MEDLINE (via PubMed) up to 31 August 2023. The writing team established the recommendations through multiple rounds of online and offline discussions. Each recommendation was graded using the evidence grading algorithm developed by the Chinese Stroke Association (CSA). The draft was reviewed and finalised by the CSA Stroke Guidelines Writing Committee. Results: This update included revisions of 15 existing recommendations and 136 new recommendations in the following areas of stroke care: emergency assessment and diagnosis of ischaemic cerebrovascular disease, acute-phase reperfusion therapy, evaluation of underlying mechanisms, antithrombotic therapy, prevention and treatment of complications, and risk factor management. Conclusions: This guideline updated the recommendations for the clinical management of ischaemic cerebrovascular disease from 2019.
- Open Access
Deviation from Personalized Blood Pressure Targets Correlates with Worse Outcome after Successful Recanalization
Background: Personalized blood pressure (BP) management for acute ischemic stroke patients after successful recanalization lacks evidence. Our study aimed to investigate whether the deviation of BP from cerebral autoregulation (CA) limits, either in duration or burden, is associated with worse outcomes. Methods: We prospectively enrolled patients with acute large anterior circulation artery occlusive stroke who had achieved successful recanalization (mTICI 2b-3). CA was determined by measuring mean velocity index (Mx) using transcranial Doppler sonography (TCD). We calculated the percent time and the burden (defined as the time-BP area) with BP outside the CA limits of each subject within 48 hours after recanalization. The outcomes included unfavorable functional outcome (mRS scored 3-6) at 90 days, early neurological deterioration (END), infarct volume growth at 7 days, and symptomatic intracranial hemorrhage (sICH) within 48 hours. Results: A total of 91 patients were enrolled. Entire failure of autoregulation was found in 31.9% (29 / 91) of patients. The burden with BP outside the CA limits was associated with poor functional outcome at 90 days (a OR per 100 h·mmHg 1.29 [95% CI, 1.05 – 1.59] P =0.018). Both the percent time and the burden with BP out of the CA limits was correlated with END (a OR per 10% time 1.38 [95% CI, 1.05 – 1.83] P =0.022, a OR per 100h·mmHg 1.22 [95% CI, 1.01 – 1.48] P =0.039). The burden of BP that decreased below the CA lower limit was associated with infarct volume growth (adjusted β per 100 h·mmHg 5.47 [95% CI, 0.13 – 10.80] P =0.045). The percent time that BP exceeded the CA upper limit was associated with sICH (a OR per 10% time 1.45 [95% CI, 1.01 – 2.07] P =0.043). Conclusions: Both the percent time and burden of BP that deviates from the autoregulation-preserved range correlate with worse outcomes after successful recanalization. Further randomized control trials are warranted to examine the effectiveness of autoregulation-guided BP targets.
Open AccessDeviation from Personalized Blood Pressure Targets Correlates with Worse Outcome after Successful Recanalization
Background: Personalized blood pressure (BP) management for acute ischemic stroke patients after successful recanalization lacks evidence. Our study aimed to investigate whether the deviation of BP from cerebral autoregulation (CA) limits, either in duration or burden, is associated with worse outcomes. Methods: We prospectively enrolled patients with acute large anterior circulation artery occlusive stroke who had achieved successful recanalization (mTICI 2b-3). CA was determined by measuring mean velocity index (Mx) using transcranial Doppler sonography (TCD). We calculated the percent time and the burden (defined as the time-BP area) with BP outside the CA limits of each subject within 48 hours after recanalization. The outcomes included unfavorable functional outcome (mRS scored 3-6) at 90 days, early neurological deterioration (END), infarct volume growth at 7 days, and symptomatic intracranial hemorrhage (sICH) within 48 hours. Results: A total of 91 patients were enrolled. Entire failure of autoregulation was found in 31.9% (29 / 91) of patients. The burden with BP outside the CA limits was associated with poor functional outcome at 90 days (a OR per 100 h·mmHg 1.29 [95% CI, 1.05 – 1.59] P =0.018). Both the percent time and the burden with BP out of the CA limits was correlated with END (a OR per 10% time 1.38 [95% CI, 1.05 – 1.83] P =0.022, a OR per 100h·mmHg 1.22 [95% CI, 1.01 – 1.48] P =0.039). The burden of BP that decreased below the CA lower limit was associated with infarct volume growth (adjusted β per 100 h·mmHg 5.47 [95% CI, 0.13 – 10.80] P =0.045). The percent time that BP exceeded the CA upper limit was associated with sICH (a OR per 10% time 1.45 [95% CI, 1.01 – 2.07] P =0.043). Conclusions: Both the percent time and burden of BP that deviates from the autoregulation-preserved range correlate with worse outcomes after successful recanalization. Further randomized control trials are warranted to examine the effectiveness of autoregulation-guided BP targets.
- Open Access
- 8 December 2021
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 7 (3) , 190-199
Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion
Background and purpose It remains controversial if endovascular treatment (EVT) can improve the outcome of patients with acute basilar artery occlusion (BAO). This study aims to compare the functional outcomes between EVT with and without intravenous thrombolysis (IVT) first in patients who had acute ischaemic stroke (AIS) due to BAO. Methods Patients who had AIS with BAO who underwent EVT within 24 hours of onset were enrolled in this multicentre cohort study, and the efficacy and safety were compared between IVT+EVT and direct EVT. The primary outcome was 90-day functional independence. All outcomes were assessed with adjusted OR (aOR) from the multivariable logistic regression. In addition, a meta-analysis was performed on all recently published pivotal studies on functional independence after EVT in patients with BAO. Results Of 310 enrolled patients with BAO, 241 (78%) were treated with direct EVT and 69 (22%) with IVT+EVT. Direct EVT was associated with a worse functional outcome (aOR, 0.46 (95% CI 0.24 to 0.85), p=0.01). IVT+EVT was associated with a lower percentage of patients who needed ≥3 passes of stent retriever (10.14% vs 20.75%). The meta-analysis regression revealed a potential positive correlation between bridging with IVT first and functional independence (r=0.14 (95% CI 0.05 to 0.24), pConclusions This study showed that compared with direct EVT, EVT with IVT first was associated with better functional outcomes in patients with BAO treated within 24 hours of onset. The meta-analysis demonstrated similar favourable efficacy of IVT first followed by EVT in patients with BAO.
- 8 December 2021
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 7 (3) , 190-199
Open AccessEndovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion
Background and purpose It remains controversial if endovascular treatment (EVT) can improve the outcome of patients with acute basilar artery occlusion (BAO). This study aims to compare the functional outcomes between EVT with and without intravenous thrombolysis (IVT) first in patients who had acute ischaemic stroke (AIS) due to BAO. Methods Patients who had AIS with BAO who underwent EVT within 24 hours of onset were enrolled in this multicentre cohort study, and the efficacy and safety were compared between IVT+EVT and direct EVT. The primary outcome was 90-day functional independence. All outcomes were assessed with adjusted OR (aOR) from the multivariable logistic regression. In addition, a meta-analysis was performed on all recently published pivotal studies on functional independence after EVT in patients with BAO. Results Of 310 enrolled patients with BAO, 241 (78%) were treated with direct EVT and 69 (22%) with IVT+EVT. Direct EVT was associated with a worse functional outcome (aOR, 0.46 (95% CI 0.24 to 0.85), p=0.01). IVT+EVT was associated with a lower percentage of patients who needed ≥3 passes of stent retriever (10.14% vs 20.75%). The meta-analysis regression revealed a potential positive correlation between bridging with IVT first and functional independence (r=0.14 (95% CI 0.05 to 0.24), pConclusions This study showed that compared with direct EVT, EVT with IVT first was associated with better functional outcomes in patients with BAO treated within 24 hours of onset. The meta-analysis demonstrated similar favourable efficacy of IVT first followed by EVT in patients with BAO.